DelfaGLP-1 Atlas

← Trials/Trial dossier/NCT07398222

Recruiting

Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study

Ultrasonographic Evaluation of Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study

Asset

Tirzepatide

Subcutaneous · GLP-1 / GIP dual

Listed sites

1

Recruiting sites

1

Enrollment

30

estimated

Study population

Healthy volunteers, Perioperative / gastric aspiration risk

Key I/E criterion

—

Primary endpoint

•Comparison of the prevalence of a full stomach after fasting

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT07398222
Org study ID90834625.3.0000.0071

Timeline

Milestones

Study start2026-01-26actual
Study first posted2026-02-09actual
Last update posted2026-02-09actual
Primary completion2026-03-20estimated
Study completion2026-03-20estimated

Assets

Investigational agents

Tirzepatide

Study populations

Who this study enrolls

Healthy volunteersPerioperative / gastric aspiration risk

Eligibility

Who can enroll

Minimum age18 Years
SexAll
Healthy volunteersAccepted
Sampling methodNon probability sample

Study population text

Thirty volunteers will be included, of whom 15 will be current users of tirzepatide and 15 will not be using the medication.

Inclusion criteria

•Adults aged 18 years or older.
•Individuals currently using tirzepatide.
•Individuals fasting for at least 8 hours for solids and 2 hours for clear liquids without residue.

Exclusion criteria

•Pregnant or postpartum individuals.
•Technical limitation for gastric ultrasound assessment.
•Presence of risk factors for gastroparesis.
•Use of prokinetic medications such as bromopride, metoclopramide or domperidone.

Endpoints (2)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Coverage by outcome category

Other clinical outcomes
1
Other (unclassified)
1

Other clinical outcomes

1 endpoint
Primary/protocol endpoint

Comparison of the prevalence of a full stomach after fasting using gastric ultrasonography in volunteers using tirzepatide versus those not using the medication.

Time frame:1 day

categorical status, event

Other (unclassified)

1 endpoint
Secondary/protocol endpoint/low confidence

demographic characteristics

Time frame:1 day

descriptive

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2
Snapshot dateJuly 1, 2026
Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)
Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.